What Researchers Did
Researchers conducted a systematic review of 8 scientific databases to identify publications on hyperbaric oxygen treatment (HBOT) for inflammatory bowel disease (IBD).
What They Found
They identified 13 studies on Crohn's disease and 6 on ulcerative colitis, all involving patients with severe disease refractory to standard treatments. Among patients with Crohn's disease, 31 out of 40 (78%) showed clinical improvements, while all 39 patients with ulcerative colitis improved with HBOT.
What This Means for Canadian Patients
For Canadian patients with severe inflammatory bowel disease refractory to standard treatments, hyperbaric oxygen therapy might offer a potential alternative for symptom improvement. However, further research is needed to establish its routine use and availability within the Canadian healthcare system.
Canadian Relevance
This systematic review did not include any studies specifically conducted in Canada or with Canadian patients.
Study Limitations
The review's findings are limited by the small number of included studies, their uncontrolled nature, and potential for publication bias.